Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones

Cell

Volumn 148, Issue 3, 2012, Pages 556-567

  Dutchak, Paul A ^a   Katafuchi, Takeshi ^b   Bookout, Angie L ^a,b   Choi, Jang Hyun ^c   Yu, Ruth T ^d   Mangelsdorf, David J ^a,b   Kliewer, Steven A ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; FIBROBLAST GROWTH FACTOR 21; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIDIABETIC ACTIVITY; ARTICLE; BODY FAT; CELL DIFFERENTIATION; EDEMA; FEEDING; GENE EXPRESSION; LIPODYSTROPHY; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUMOYLATION; WEIGHT GAIN;

MUS;

EID: 84863012459     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2011.11.062     Document Type: Article

References (60)

1. M. Adams, M.J. Reginato, D. Shao, M.A. Lazar, and V.K. Chatterjee Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site J. Biol. Chem. 272 1997 5128 5132 (Pubitemid 27090069)
2. P. Arner, A. Pettersson, P.J. Mitchell, J.D. Dunbar, A. Kharitonenkov, and M. Rydén FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity FEBS Lett. 582 2008 1725 1730
3. M.K. Badman, P. Pissios, A.R. Kennedy, G. Koukos, J.S. Flier, and E. Maratos-Flier Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states Cell Metab. 5 2007 426 437 (Pubitemid 46825495)
4. M.K. Badman, A. Koester, J.S. Flier, A. Kharitonenkov, and E. Maratos-Flier Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis Endocrinology 150 2009 4931 4940
5. E.D. Berglund, C.Y. Li, H.A. Bina, S.E. Lynes, M.D. Michael, A.B. Shanafelt, A. Kharitonenkov, and D.H. Wasserman Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity Endocrinology 150 2009 4084 4093
6. Z. Cao, R.M. Umek, and S.L. McKnight Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells Genes Dev. 5 1991 1538 1552 (Pubitemid 21906060)
7. A. Chawla, E.J. Schwarz, D.D. Dimaculangan, and M.A. Lazar Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation Endocrinology 135 1994 798 800 (Pubitemid 24241266)
8. J.H. Choi, A.S. Banks, J.L. Estall, S. Kajimura, P. Boström, D. Laznik, J.L. Ruas, M.J. Chalmers, T.M. Kamenecka, and M. Blüher Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5 Nature 466 2010 451 456
9. C. Christodoulides, P. Dyson, D. Sprecher, K. Tsintzas, and F. Karpe Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man J. Clin. Endocrinol. Metab. 94 2009 3594 3601
10. T. Coskun, H.A. Bina, M.A. Schneider, J.D. Dunbar, C.C. Hu, Y. Chen, D.E. Moller, and A. Kharitonenkov Fibroblast growth factor 21 corrects obesity in mice Endocrinology 149 2008 6018 6027
11. J. Dushay, P.C. Chui, G.S. Gopalakrishnan, M. Varela-Rey, M. Crawley, F.M. Fisher, M.K. Badman, M.L. Martinez-Chantar, and E. Maratos-Flier Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease Gastroenterology 139 2010 456 463
12. F.M. Fisher, P.C. Chui, P.J. Antonellis, H.A. Bina, A. Kharitonenkov, J.S. Flier, and E. Maratos-Flier Obesity is a fibroblast growth factor 21 (FGF21)-resistant state Diabetes 59 2010 2781 2789
13. Z.E. Floyd, and J.M. Stephens Control of peroxisome proliferator- activated receptor gamma2 stability and activity by SUMOylation Obes. Res. 12 2004 921 928 (Pubitemid 41202392)
14. K. Fon Tacer, A.L. Bookout, X. Ding, H. Kurosu, G.B. John, L. Wang, R. Goetz, M. Mohammadi, M. Kuro-o, D.J. Mangelsdorf, and S.A. Kliewer Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse Mol. Endocrinol. 24 2010 2050 2064
15. Y. Guan, C. Hao, D.R. Cha, R. Rao, W. Lu, D.E. Kohan, M.A. Magnuson, R. Redha, Y. Zhang, and M.D. Breyer Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption Nat. Med. 11 2005 861 866 (Pubitemid 41161118)
16. E. Hondares, M. Rosell, F.J. Gonzalez, M. Giralt, R. Iglesias, and F. Villarroya Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat Cell Metab. 11 2010 206 212
17. Y. Hotta, H. Nakamura, M. Konishi, Y. Murata, H. Takagi, S. Matsumura, K. Inoue, T. Fushiki, and N. Itoh Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver Endocrinology 150 2009 4625 4633
18. E. Hu, J.B. Kim, P. Sarraf, and B.M. Spiegelman Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma Science 274 1996 2100 2103 (Pubitemid 27020707)
19. T. Inagaki, P. Dutchak, G. Zhao, X. Ding, L. Gautron, V. Parameswara, Y. Li, R. Goetz, M. Mohammadi, and V. Esser Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21 Cell Metab. 5 2007 415 425 (Pubitemid 46825496)
20. T. Inagaki, V.Y. Lin, R. Goetz, M. Mohammadi, D.J. Mangelsdorf, and S.A. Kliewer Inhibition of growth hormone signaling by the fasting-induced hormone FGF21 Cell Metab. 8 2008 77 83
21. C.L. Johnson, J.Y. Weston, S.A. Chadi, E.N. Fazio, M.W. Huff, A. Kharitonenkov, A. Köester, and C.L. Pin Fibroblast growth factor 21 reduces the severity of cerulein-induced pancreatitis in mice Gastroenterology 137 2009 1795 1804
22. A. Kharitonenkov, T.L. Shiyanova, A. Koester, A.M. Ford, R. Micanovic, E.J. Galbreath, G.E. Sandusky, L.J. Hammond, J.S. Moyers, and R.A. Owens FGF-21 as a novel metabolic regulator J. Clin. Invest. 115 2005 1627 1635 (Pubitemid 40814671)
23. A. Kharitonenkov, V.J. Wroblewski, A. Koester, Y.F. Chen, C.K. Clutinger, X.T. Tigno, B.C. Hansen, A.B. Shanafelt, and G.J. Etgen The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21 Endocrinology 148 2007 774 781 (Pubitemid 46143178)
24. H. Kurosu, M. Choi, Y. Ogawa, A.S. Dickson, R. Goetz, A.V. Eliseenkova, M. Mohammadi, K.P. Rosenblatt, S.A. Kliewer, and M. Kuro-o Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21 J. Biol. Chem. 282 2007 26687 26695 (Pubitemid 47501965)
25. M.I. Lefterova, Y. Zhang, D.J. Steger, M. Schupp, J. Schug, A. Cristancho, D. Feng, D. Zhuo, C.J. Stoeckert Jr.; X.S. Liu, and M.A. Lazar PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale Genes Dev. 22 2008 2941 2952
26. K. Li, L. Li, M. Yang, H. Zong, H. Liu, and G. Yang Effects of rosiglitazone on fasting plasma fibroblast growth factor-21 levels in patients with type 2 diabetes mellitus Eur. J. Endocrinol. 161 2009 391 395
27. X. Li, H. Ge, J. Weiszmann, R. Hecht, Y.S. Li, M.M. Véniant, J. Xu, X. Wu, R. Lindberg, and Y. Li Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice FEBS Lett. 583 2009 3230 3234
28. T. Lundsen, M.C. Hunt, L.M. Nilsson, S. Sanyal, B. Angelin, S.E. Alexson, and M. Rudling PPARalpha is a key regulator of hepatic FGF21 Biochem. Biophys. Res. Commun. 360 2007 437 440 (Pubitemid 47039157)
29. K. Mai, J. Andres, K. Biedasek, J. Weicht, T. Bobbert, M. Sabath, S. Meinus, F. Reinecke, M. Möhlig, and M.O. Weickert Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21 Diabetes 58 2009 1532 1538
30. J.S. Moyers, T.L. Shiyanova, F. Mehrbod, J.D. Dunbar, T.W. Noblitt, K.A. Otto, A. Reifel-Miller, and A. Kharitonenkov Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling J. Cell. Physiol. 210 2007 1 6 (Pubitemid 44904695)
31. E.S. Muise, B. Azzolina, D.W. Kuo, M. El-Sherbeini, Y. Tan, X. Yuan, J. Mu, J.R. Thompson, J.P. Berger, and K.K. Wong Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states Mol. Pharmacol. 74 2008 403 412
32. Y. Ogawa, H. Kurosu, M. Yamamoto, A. Nandi, K.P. Rosenblatt, R. Goetz, A.V. Eliseenkova, M. Mohammadi, and M. Kuro-o BetaKlotho is required for metabolic activity of fibroblast growth factor 21 Proc. Natl. Acad. Sci. USA 104 2007 7432 7437 (Pubitemid 47185923)
33. T. Ohshima, H. Koga, and K. Shimotohno Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification J. Biol. Chem. 279 2004 29551 29557 (Pubitemid 38915836)
34. G. Pascual, A.L. Fong, S. Ogawa, A. Gamliel, A.C. Li, V. Perissi, D.W. Rose, T.M. Willson, M.G. Rosenfeld, and C.K. Glass A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma Nature 437 2005 759 763 (Pubitemid 41486547)
35. M.J. Potthoff, T. Inagaki, S. Satapati, X. Ding, T. He, R. Goetz, M. Mohammadi, B.N. Finck, D.J. Mangelsdorf, S.A. Kliewer, and S.C. Burgess FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response Proc. Natl. Acad. Sci. USA 106 2009 10853 10858
36. L. Reshef, Y. Olswang, H. Cassuto, B. Blum, C.M. Croniger, S.C. Kalhan, S.M. Tilghman, and R.W. Hanson Glyceroneogenesis and the triglyceride/fatty acid cycle J. Biol. Chem. 278 2003 30413 30416 (Pubitemid 36994541)
37. E.D. Rosen, P. Sarraf, A.E. Troy, G. Bradwin, K. Moore, D.S. Milstone, B.M. Spiegelman, and R.M. Mortensen PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro Mol. Cell 4 1999 611 617 (Pubitemid 29531140)
38. D.A. Sarruf, J.P. Thaler, G.J. Morton, J. German, J.D. Fischer, K. Ogimoto, and M.W. Schwartz Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats Diabetes 59 2010 1817 1824
39. D. Shao, S.M. Rangwala, S.T. Bailey, S.L. Krakow, M.J. Reginato, and M.A. Lazar Interdomain communication regulating ligand binding by PPAR-gamma Nature 396 1998 377 380 (Pubitemid 28557399)
40. B.M. Spiegelman, and J.S. Flier Obesity and the regulation of energy balance Cell 104 2001 531 543 (Pubitemid 32201948)
41. M. Suzuki, Y. Uehara, K. Motomura-Matsuzaka, J. Oki, Y. Koyama, M. Kimura, M. Asada, A. Komi-Kuramochi, S. Oka, and T. Imamura betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c Mol. Endocrinol. 22 2008 1006 1014 (Pubitemid 351482834)
42. P. Tontonoz, and B.M. Spiegelman Fat and beyond: the diverse biology of PPARgamma Annu. Rev. Biochem. 77 2008 289 312
43. P. Tontonoz, E. Hu, R.A. Graves, A.I. Budavari, and B.M. Spiegelman mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer Genes Dev. 8 1994 1224 1234
44. P. Tontonoz, E. Hu, and B.M. Spiegelman Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor Cell 79 1994 1147 1156
45. H. Wang, L. Qiang, and S.R. Farmer Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes Mol. Cell. Biol. 28 2008 188 200
46. W. Wente, A.M. Efanov, M. Brenner, A. Kharitonenkov, A. Köster, G.E. Sandusky, S. Sewing, I. Treinies, H. Zitzer, and J. Gromada Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways Diabetes 55 2006 2470 2478 (Pubitemid 44871147)
47. T.M. Willson, M.H. Lambert, and S.A. Kliewer Peroxisome proliferator-activated receptor gamma and metabolic disease Annu. Rev. Biochem. 70 2001 341 367 (Pubitemid 32662214)
48. Z. Wu, Y. Xie, N.L. Bucher, and S.R. Farmer Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis Genes Dev. 9 1995 2350 2363
49. Z. Wu, N.L. Bucher, and S.R. Farmer Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids Mol. Cell. Biol. 16 1996 4128 4136 (Pubitemid 26251212)
50. Z. Wu, Y. Xie, R.F. Morrison, N.L. Bucher, and S.R. Farmer PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes J. Clin. Invest. 101 1998 22 32 (Pubitemid 28058899)
51. Z. Wu, E.D. Rosen, R. Brun, S. Hauser, G. Adelmant, A.E. Troy, C. McKeon, G.J. Darlington, and B.M. Spiegelman Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity Mol. Cell 3 1999 151 158 (Pubitemid 29292616)
52. J. Xu, D.J. Lloyd, C. Hale, S. Stanislaus, M. Chen, G. Sivits, S. Vonderfecht, R. Hecht, Y.S. Li, and R.A. Lindberg Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice Diabetes 58 2009 250 259
53. D. Yamashita, T. Yamaguchi, M. Shimizu, N. Nakata, F. Hirose, and T. Osumi The transactivating function of peroxisome proliferator-activated receptor gamma is negatively regulated by SUMO conjugation in the amino-terminal domain Genes Cells 9 2004 1017 1029 (Pubitemid 39467975)
54. W.C. Yeh, Z. Cao, M. Classon, and S.L. McKnight Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins Genes Dev. 9 1995 168 181
55. H. Zhang, A. Zhang, D.E. Kohan, R.D. Nelson, F.J. Gonzalez, and T. Yang Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention Proc. Natl. Acad. Sci. USA 102 2005 9406 9411 (Pubitemid 40923576)
56. X. Zhang, D.C. Yeung, M. Karpisek, D. Stejskal, Z.G. Zhou, F. Liu, R.L. Wong, W.S. Chow, A.W. Tso, K.S. Lam, and A. Xu Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans Diabetes 57 2008 1246 1253
57. Bookout, A.L.; and Mangelsdorf, D.J. (2003). Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl. Recept. Signal. 1, e012.
58. Choi, J.H.; Banks, A.S.; Estall, J.L.; Kajimura, S.; Boström, P.; Laznik, D.; Ruas, J.L.; Chalmers, M.J.; Kamenecka, T.M.; Blüher, M.; et al. (2010). Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature 466, 451-456.
59. Folch, J.; Lees, M.; and Sloane Stanley, G.H. (1957). A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497-509.
60. Ramírez-Zacarías, J.L.; Castro-Muñozledo, F.; and Kuri-Harcuch, W. (1992). Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry 97, 493-497.